M&A Deal Summary |
|
|---|---|
| Date | 2004-10-27 |
| Target | Merck KGaA - 5-HT2 Novel Compound |
| Sector | Life Science |
| Buyer(s) | Lilly |
| Sellers(s) | Merck |
| Deal Type | Divestiture |
| Deal Value | 23M EUR |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1876 |
| Sector | Life Science |
| Employees | 43,000 |
| Revenue | 45.0B USD (2024) |
Lilly discovers, develops, manufactures, and markets products in two business segments—human pharmaceutical products and animal health products. The mission of its human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Most of the products Lilly sells were discovered or developed by its own scientists, and the Company's success depends to a great extent on its ability to continue to discover, develop, and bring to market innovative new medicines. The company's animal health business, operating through its Elanco division, develops, manufactures, and markets products for both food animals and companion animals. The company manufactures and distributes its products through facilities in the US, Puerto Rico, and 11 other countries. Lilly was founded in 1876 and is based in Indianapolis, Indiana.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 38 |
| Sector: Life Science M&A | 2 of 31 |
| Type: Divestiture M&A Deals | 2 of 7 |
| Country: Germany M&A | 1 of 1 |
| Year: 2004 M&A | 1 of 1 |
| Size (of disclosed) | 21 of 21 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-04-06 |
Kinetra
Nashville, Tennessee, United States Kinetra LLC is a provider of clinical document distribution solutions and administrative transactions to IDNs, large hospitals and payors. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-10-17 |
ICOS
Bothell, Washington, United States ICOS Corp. a biotechnology company based in Bothell, Washington. |
Buy | $2.1B |
| Category | Company |
|---|---|
| Founded | 1668 |
| Sector | Diversified |
| Employees | 64,011 |
| Revenue | 21.2B EUR (2024) |
Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 8 |
| Sector: Life Science M&A | 1 of 4 |
| Type: Divestiture M&A Deals | 2 of 8 |
| Country: Germany M&A | 1 of 5 |
| Year: 2004 M&A | 2 of 2 |
| Size (of disclosed) | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-02-16 |
VWR International
Radnor, Pennsylvania, United States VWR International LLC is a distributor of products, services and solutions to laboratory and production facilities. VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. |
Sell | $1.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-05 |
Serono S.A.
Darmstadt, Germany Serono S.A. a biopharmaceutical company, engages in development of prescription medicines of chemical and biological origin in specialist indications. |
Buy | - |
